Clinical Trial Update: Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase II study of Everolimus in children and adolescents with refractory or relapsed rhabdomyosarcoma and other soft tissue sarcomas; the current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Sidnei Epelman | Conditions: Refractory or Relapsed RMS and Soft Tissue Sarcomas | Phase 2 | Status: UNKNOWN